Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- Registration Number
- NCT04402801
- Lead Sponsor
- University of Virginia
- Brief Summary
Adult patients with Cystic Fibrosis who are seen at the specialty CF clinic at University of Virginia will be given an option to utilize telemedicine instead of in-person visits for standard clinic visits. Health information from standard of care visits including FEV1, exacerbations, leading to oral or intravenous antibiotics, laboratory results, hospitalization records, and responses to health questionnaires will be recorded for research purposes. Data collected for the research study will be compared to baseline and previous years to determine if there are any deleterious effects for those who transition to telemedicine clinic visits.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
- Adult patients (18-year-old and older) with CF seen in the UVA adult CF clinic who agree to participate in the study.
- Patients who cannot consent to the research study. In addition, prisoners will not be included.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1 stability 12 months A change of 10% or more in FEV1 percent predicted will be considered significant; FEV1 pre and pos covid telemedicine implementation will be compared
- Secondary Outcome Measures
Name Time Method Exacerbation rate 12 months Exacerbation rate pre and pos covid telemedicine implementation will be compared
Trial Locations
- Locations (1)
University of Virginia Health System
🇺🇸Charlottesville, Virginia, United States